Maghemite-containing PLGA-PEG-based polymeric nanoparticles for siRNA delivery: Toxicity and silencing evaluation

4Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Gene therapy based on small interfering RNA (siRNA) has emerged as an exciting new therapeutic approach. In this work, incorporation of PEI into poly(d,l-lactide-co-glycolide)-poly(ethylene glycol) (PLGA-b-PEG) particles has been shown to be quite effective in the development of corresponding gene delivery systems, and encapsulation of magnetic nanoparticles as an MRI contrast agent, resulted in unique theranostic nanoparticles.

Cite

CITATION STYLE

APA

Lellouche, E., Locatelli, E., Israel, L. L., Naddaka, M., Kurlander, E., Michaeli, S., … Franchini, M. C. (2017). Maghemite-containing PLGA-PEG-based polymeric nanoparticles for siRNA delivery: Toxicity and silencing evaluation. RSC Advances, 7(43), 26912–26920. https://doi.org/10.1039/c7ra00517b

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free